Cancer Immunology, Immunotherapy

Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas

Krzysztof Warzocha, Patricia Ribeiro, Nathalie Renard, Jacques Bienvenu, Carloe Charlot, Bertrand Coiffier, Gilles Salles

Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines

Michael Graner, Amy Raymond, Emmanuel Akporiaye, Emmanuel Katsanis

Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas

Bernhard Hemmerlein, Antje Markus, Marlen Wehner, Alexander Kugler, Frank Zschunke, Heinz-Joachim Radzun

Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcγRI and the epidermal growth factor receptor

Paul K. Wallace, Jean-Loup Romet-Lemonne, Mohammed Chokri, Lloyd H. Kasper, Michael W. Fanger, Camilo E. Fadul

Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides

Brett W. Anderson, Andrezj P. Kudelka, Toshie Honda, Marilyn S. Pollack, David M. Gershenson, Michael A. Gillogly, James L. Murray, Constantin G. Ioannides

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

Heidi Hörig, David S. Lee, William Conkright, Joe Divito, Henry Hasson, Michelle LaMare, Audrey Rivera, David Park, John Tine, Ken Guito, Kwong Wong-Yok Tsang, Jeffrey Schlom, Howard L. Kaufman

Erratum: Cancer Immunol Immunother (2000) 49: 314–318